Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Net Income (2019 - 2026)

Strata Critical Medical (SRTA) reported Net Income of -$248000.0 for Q1 2026, up 86.82% year-over-year from -$132751.3 in Q1 2025, and up 92.8% on a QoQ basis from -$3.4 million in Q4 2025.

Strata Critical Medical (SRTA) has 8 years of Net Income data on file, last reported at -$248000.0 in Q1 2026.

  • Quarterly Net Income rose 86.82% year-over-year to -$248000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.6 million (up 601.28% YoY) and the FY2025 annual result came in at $61.4 million, up 650.99% from the prior year.
  • Net Income advanced to -$248000.0 in Q1 2026 per SRTA's latest filing, from -$3.4 million in the prior quarter.
  • Across five years, Net Income topped out at $67.1 million in Q3 2025 and bottomed at -$33.9 million in Q4 2023.
  • The 5-year median for Net Income is -$3.4 million (2025), against an average of -$1.0 million.
  • The widest annual swing landed in 2022, when Net Income sank 918.71%; it then surged 1726.11% in 2025.
  • Tracing SRTA's Net Income over 5 years: stood at $8.4 million in 2022, then plunged by 503.48% to -$33.9 million in 2023, then jumped by 93.04% to -$2.4 million in 2024, then tumbled by 45.79% to -$3.4 million in 2025, then surged by 92.8% to -$248000.0 in 2026.
  • Per Business Quant, the three latest SRTA Net Income figures stand at -$248000.0 (Q1 2026), -$3.4 million (Q4 2025), and $67.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn 1.86 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 906.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 275.04 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 15.90 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn 99.76 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn 358.68 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn 68.68 Mn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 66.30 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn 80.67 Mn
10 Strata Critical Medical 538.39 Mn 479.60 Mn 14.12 Mn -248,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -248,000.00
Dec 31, 2025 -3.45 Mn
Sep 30, 2025 67.07 Mn
Jun 30, 2025 -3.74 Mn
Mar 31, 2025 -1.88 Mn
Dec 31, 2024 -2.36 Mn
Sep 30, 2024 3.67 Mn
Jun 30, 2024 -11.33 Mn
Mar 31, 2024 -4.23 Mn
Dec 31, 2023 -33.94 Mn
Sep 30, 2023 289,000.00
Jun 30, 2023 -12.23 Mn
Mar 31, 2023 -10.19 Mn
Jun 30, 2022 8.41 Mn
Mar 31, 2022 -11.01 Mn
Sep 30, 2021 -9.18 Mn
Jun 30, 2021 -7.77 Mn
Mar 31, 2021 -1.08 Mn
Sep 30, 2020 -100,155.00
Jun 30, 2020 -5,982.00
Mar 31, 2020 5.70 Mn
Dec 31, 2019 2.33 Mn
Sep 30, 2019 99,139.00
Jun 30, 2019 -1,000.00